SUNDARAM PREETHI (Chief Product Devel. Officer) exercised options at CATALYST PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/30/2025ACC: 0001161697-25-000495
Officer· Chief Product Devel. Officer
Since Jul 2021
-2.37K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
6.67K acquired · 9.04K disposed
Non-Derivative Transactions2
Common Stock, par value $0.001 per share
Direct
Shares
+6.67K
Price / share
—
Trade value
—
% of position
13.2%
12/29/2025
50.51K→57.17K
Common Stock, par value $0.001 per share
Direct
Shares
−2.37K
Price / share
—
Trade value
—
% of position
4.1%
12/29/2025
57.17K→54.80K
Total
Net shares
+4.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Direct | 12/29/2025 | M · Option Exercise | +6.67K | — | — | 13.2% | 50.51K | 57.17K |
| Common Stock, par value $0.001 per share Direct | 12/29/2025 | F · Tax Withholding | −2.37K | — | — | 4.1% | 57.17K | 54.80K |
| Total | +4.30K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.67K shares
Shares
−6.67K
Strike price
Held after
798.44K
Exercisable
—
12/29/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.67K shares | 12/29/2025 | M · Option Exercise | −6.67K | — | 798.44K |